Answers are grounded in this paper and cite their sources.
Research is needed to determine clinical criteria as to who should be using cannabis therapeutically, how to implement therapeutic use of cannabis in opioid agonist treatment (OAT) settings optimally, and other behavioral approaches to improving OAT retention and outcomes.
No takes yet. Share an insight, caveat, or question.
Timko et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: